Its conspicuous that the only reference to a significant level of pain reduction occurred with the combination of Rexlemestrocel AND Hyaluronic Acid together... so Rexlemestrocel on its own didn't reach significance?
Maybe the peer review can shed some more light. Once again the announcement doesn't mention that it met the primary endpoint...
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-167
-
- There are more pages in this discussion • 937 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |